Vaxart (VXRT) held its 2026 annual meeting, with shareholders re-electing the full slate of directors and ratifying the auditor. The company’s non-binding advisory proposal on executive compensation was rejected, suggesting shareholder pushback on pay policy, but there were no stated financial changes or guidance updates.
Vaxart (VXRT) held its 2026 annual meeting, with shareholders re-electing the full slate of directors and ratifying the auditor. The company’s non-binding advisory proposal on executive compensation was rejected, suggesting shareholder pushback on pay policy, but there were no stated financial changes or guidance updates.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
